Finally, treatment with Pan-HER induced ERBB receptor regression and downregulation of T-DM1-resistant HR6 and HCC1954 tumors, and prevented also tumor recurrences after therapy was stopped
Finally, treatment with Pan-HER induced ERBB receptor regression and downregulation of T-DM1-resistant HR6 and HCC1954 tumors, and prevented also tumor recurrences after therapy was stopped. We know that some restrictions…